{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:05Z","timestamp":1792788845461,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Foundation Fighting Blindness, Foundation for Retinal Research"},{"name":"Choroideremia Research Foundation","id":[{"id":"https:\/\/ror.org\/039m3qq17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Foundation Fighting Blindness"},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["R21EY020662"],"award-info":[{"award-number":["R21EY020662"]}]},{"name":"NIH","award":["8DP1EY023177"],"award-info":[{"award-number":["8DP1EY023177"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brenda and Matthew Shapiro Stewardship"},{"name":"Robert and Susan Heidenberg Investigative Research Fund for Ocular Gene Therapy"},{"name":"Paul and Evanina Mackall Foundation Trust"},{"name":"Center for Advanced Retinal and Ocular Therapeutics"},{"DOI":"10.13039\/100001205","name":"F.M. Kirby Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001205","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ymthe.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T20:48:08Z","timestamp":1491425288000},"page":"1076-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward"],"prefix":"10.1016","volume":"25","author":[{"given":"Jean","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.03.008_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.gt.3302030","article-title":"Immune response following intraocular delivery of recombinant viral vectors","volume":"10","author":"Bennett","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/347677a0","article-title":"Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase","volume":"347","author":"Bowes","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.008_bib3","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1073\/pnas.88.19.8322","article-title":"Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse","volume":"88","author":"Pittler","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib4","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1073\/pnas.90.20.9616","article-title":"PCR analysis of DNA from 70-year-old sections of rodless retina demonstrates identity with the mouse rd defect","volume":"90","author":"Pittler","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib5","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1073\/pnas.90.9.3968","article-title":"Irish setter dogs affected with rod\/cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene","volume":"90","author":"Suber","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nm0696-649","article-title":"Photoreceptor cell rescue in retinal degeneration (rd) mice by in\u00a0vivo gene therapy","volume":"2","author":"Bennett","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib7","first-page":"S777","article-title":"Adenovirus-mediated gene transfer to canine retinal photoreceptors: effects of inflammation","volume":"36","author":"Maguire","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib8","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1073\/pnas.94.13.6916","article-title":"Efficient photoreceptor-targeted gene expression in\u00a0vivo by recombinant adeno-associated virus","volume":"94","author":"Flannery","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib9","first-page":"2857","article-title":"Real-time, noninvasive in\u00a0vivo assessment of adeno-associated virus-mediated retinal transduction","volume":"38","author":"Bennett","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gt.3300440","article-title":"Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration","volume":"4","author":"Jomary","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib11","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult\u00a0rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib12","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient non-viral ocular gene transfer with compacted DNA nanoparticles","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2017.03.008_bib13","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1096\/fj.09-139147","article-title":"Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa","volume":"24","author":"Cai","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2017.03.008_bib14","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1096\/fj.15-270363","article-title":"Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype","volume":"29","author":"Han","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2017.03.008_bib15","doi-asserted-by":"crossref","first-page":"e5290","DOI":"10.1371\/journal.pone.0005290","article-title":"A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles","volume":"4","author":"Cai","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2017.03.008_bib16","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/7.12.1893","article-title":"Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration","volume":"7","author":"Kumar-Singh","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/gt.2008.78","article-title":"Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy","volume":"15","author":"Kong","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib18","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/gt.2011.153","article-title":"Ocular gene delivery using lentiviral vectors","volume":"19","author":"Balaggan","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib20","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib21","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0042-6989(98)00308-3","article-title":"Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV","volume":"39","author":"Dudus","year":"1999","journal-title":"Vision Res."},{"key":"10.1016\/j.ymthe.2017.03.008_bib22","series-title":"Retina","first-page":"652","article-title":"Retina","author":"Bennett","year":"2013"},{"key":"10.1016\/j.ymthe.2017.03.008_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gt.2011.163","article-title":"Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9","volume":"19","author":"Dalkara","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib26","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib27","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/emmm.201404077","article-title":"Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter","volume":"6","author":"Cronin","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/hum.2016.111","article-title":"Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina","volume":"28","author":"Ramachandran","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2017.03.008_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1596","article-title":"Restoration of cone vision in a mouse model of achromatopsia","volume":"13","author":"Alexander","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mt.2014.154","article-title":"Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice","volume":"23","author":"Mac\u00e9","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/gt.2011.3","article-title":"AAV-mediated photoreceptor transduction of the pig cone-enriched retina","volume":"18","author":"Mussolino","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/hum.2010.140","article-title":"AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa","volume":"22","author":"Mao","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib35","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.07-0257","article-title":"AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter","volume":"48","author":"Khani","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib36","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1073\/pnas.94.19.10319","article-title":"Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector","volume":"94","author":"Miyoshi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jgm.1115","article-title":"Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors","volume":"9","author":"Nicoud","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/hum.2005.16.178","article-title":"Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates","volume":"16","author":"Lebherz","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib39","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/srep17105","article-title":"An autogenously regulated expression system for gene therapeutic ocular applications","volume":"5","author":"Sochor","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2017.03.008_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ophtha.2016.10.022","article-title":"Natural history of the central structural abnormalities in choroideremia: a prospective cross-sectional study","volume":"124","author":"Aleman","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2017.03.008_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/genes8020053","article-title":"Correction of monogenic and common retinal disorders with gene therapy","volume":"8","author":"Sengillo","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2017.03.008_bib42","unstructured":"FDA (2011). Briefing Document: FDA Cellular, Tissue, and Gene Therapies Advisory Committee. CTGTAC Meeting #52; Cellular and Gene Therapies for Retinal Disorders, June 29, 2011 (FDA Cellular, Tissue, and Gene Therapies Advisory Committee)."},{"issue":"Pt B","key":"10.1016\/j.ymthe.2017.03.008_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.visres.2015.03.001","article-title":"Subretinal visual implant alpha IMS\u2014clinical trial interim report","volume":"111","author":"Stingl","year":"2015","journal-title":"Vision Res."},{"key":"10.1016\/j.ymthe.2017.03.008_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12886-016-0225-1","article-title":"Worldwide Argus II implantation: recommendations to optimize patient outcomes","volume":"16","author":"Ghodasra","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12886-016-0259-4","article-title":"Erratum to: Worldwide Argus II implantation: recommendations to optimize patient outcomes","volume":"16","author":"Ghodasra","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cxo.12359","article-title":"An analysis of observer-rated functional vision in patients implanted with the Argus II retinal prosthesis system at three years","volume":"99","author":"Geruschat","year":"2016","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.ymthe.2017.03.008_bib47","doi-asserted-by":"crossref","first-page":"e86068","DOI":"10.1371\/journal.pone.0086068","article-title":"fMRI of retina-originated phosphenes experienced by patients with Leber congenital amaurosis","volume":"9","author":"Ashtari","year":"2014","journal-title":"PLoS One"},{"issue":"10S","key":"10.1016\/j.ymthe.2017.03.008_bib48","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.ophtha.2016.06.041","article-title":"Gene therapy and stem cell transplantation in retinal disease: the new frontier","volume":"123","author":"MacLaren","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2017.03.008_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ymthe.2003.11.013","article-title":"In utero gene therapy rescues vision in a murine model of congenital blindness","volume":"9","author":"Dejneka","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib50","series-title":"Foundations of Sensation and Perception","first-page":"196","article-title":"Visual physiology","author":"Mather","year":"2008"},{"key":"10.1016\/j.ymthe.2017.03.008_bib51","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1172\/JCI57377","article-title":"The human visual cortex responds to gene therapy-mediated recovery of retinal function","volume":"121","author":"Ashtari","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.03.008_bib52","doi-asserted-by":"crossref","first-page":"296ra110","DOI":"10.1126\/scitranslmed.aaa8791","article-title":"Plasticity of the human visual system after retinal gene therapy in patients with Leber\u2019s congenital amaurosis","volume":"7","author":"Ashtari","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib53","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1200\/JCO.2004.00.1883","article-title":"Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir","volume":"23","author":"Ch\u00e9vez-Barrios","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib55","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib56","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib57","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1\u00a0trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2017.03.008_bib59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/APO.0000000000000222","article-title":"Gene therapy for age-related macular degeneration","volume":"5","author":"Constable","year":"2016","journal-title":"Asia Pac. J. Ophthalmol. (Phila.)"},{"key":"10.1016\/j.ymthe.2017.03.008_bib60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2017.03.008_bib61","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1073\/pnas.0504167102","article-title":"Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle","volume":"102","author":"Redmond","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of Leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib65","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ophtha.2016.03.003","article-title":"Results at 2\u00a0years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood-onset retinal dystrophy","volume":"123","author":"Weleber","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2017.03.008_bib66","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib67","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib68","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib69","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMc1509501","article-title":"Visual acuity after retinal gene therapy for choroideremia","volume":"374","author":"Edwards","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib70","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2017.03.008_bib71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","article-title":"Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial","volume":"135","author":"Ghazi","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ebiom.2016.11.016","article-title":"Phase 2a randomized clinical trial: safety and post hoc analysis of subretinal rAAV.sFLT-1 for wet age-related macular degeneration","volume":"14","author":"Constable","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2017.03.008_bib73","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1\u00a0randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2017.03.008_bib74","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In\u00a0vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib75","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","article-title":"Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease","volume":"24","author":"Trapani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib76","doi-asserted-by":"crossref","first-page":"e61396","DOI":"10.1371\/journal.pone.0061396","article-title":"AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models","volume":"8","author":"Vasireddy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2017.03.008_bib77","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2017.03.008_bib78","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/S1525-0016(16)38784-6","article-title":"Gene therapy-mediated reversal of congenital blindness: demonstration of efficacy in a phase 1 safety trial","volume":"17","author":"Bennett","year":"2009","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2017.03.008_bib79","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib80","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ophtha.2012.11.048","article-title":"Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2","volume":"120","author":"Testa","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2017.03.008_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","article-title":"Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years","volume":"130","author":"Jacobson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib82","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMc0903652","article-title":"Vision 1\u00a0year after gene therapy for Leber\u2019s congenital amaurosis","volume":"361","author":"Cideciyan","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib83","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib84","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib85","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/hum.2010.047","article-title":"Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel","volume":"21","author":"Banin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib86","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and safety of rAAV2-ND4 treatment for Leber\u2019s hereditary optic neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2017.03.008_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.03.008_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1126\/science.2937147","article-title":"Molecular genetics of human color vision: the genes encoding blue, green, and red pigments","volume":"232","author":"Nathans","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.03.008_bib89","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4161\/cc.3.7.1002","article-title":"The first knockout mouse model of retinoblastoma","volume":"3","author":"Zhang","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2017.03.008_bib90","first-page":"2082","article-title":"Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors","volume":"8","author":"Goddard","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib91","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.84.24.9059","article-title":"Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein","volume":"84","author":"Friend","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib92","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.06-0789","article-title":"The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse","volume":"48","author":"Qi","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib94","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.03.008_bib95","first-page":"3556","article-title":"Choroideremia mouse model generated by conditional Rep1 knock-out","volume":"46","author":"Seabra","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/347674a0","article-title":"Cloning of a gene that is rearranged in patients with choroideraemia","volume":"347","author":"Cremers","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.008_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00205174","article-title":"Cloning of the breakpoints of a deletion associated with choroidermia","volume":"86","author":"Cremers","year":"1990","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib98","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0896-6273(92)90236-7","article-title":"Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa","volume":"9","author":"Olsson","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2017.03.008_bib99","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng0297-216","article-title":"Retinopathy induced in mice by targeted disruption of the rhodopsin gene","volume":"15","author":"Humphries","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/343364a0","article-title":"A point mutation of the rhodopsin gene in one form of retinitis pigmentosa","volume":"343","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.008_bib101","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM199011083231903","article-title":"Mutations within the rhodopsin gene in\u00a0patients with autosomal dominant retinitis pigmentosa","volume":"323","author":"Dryja","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.03.008_bib102","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0888-7543(91)90051-F","article-title":"Autosomal dominant retinitis pigmentosa: a mutation in codon 178 of the rhodopsin gene in two families of Celtic origin","volume":"11","author":"Farrar","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2017.03.008_bib103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/hmg\/5.1.51","article-title":"An animal model for Norrie disease (ND): gene targeting of the mouse ND gene","volume":"5","author":"Berger","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/hmg\/1.7.461","article-title":"Mutations in the candidate gene for Norrie disease","volume":"1","author":"Berger","year":"1992","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2014.01.008","article-title":"The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder","volume":"111","author":"Hiebler","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.03.008_bib106","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1546315","article-title":"A human gene responsible for Zellweger syndrome that affects peroxisome assembly","volume":"255","author":"Shimozawa","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.03.008_bib107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/75621","article-title":"Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis","volume":"25","author":"Clarke","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib108","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0896-6273(92)90137-3","article-title":"Cloning of the cDNA for a novel photoreceptor membrane protein (rom-1) identifies a disk rim protein family implicated in human retinopathies","volume":"8","author":"Bascom","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2017.03.008_bib109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/genetics\/130.1.163","article-title":"Mitochondrial DNA complex I and III mutations associated with Leber\u2019s hereditary optic neuropathy","volume":"130","author":"Brown","year":"1992","journal-title":"Genetics"},{"key":"10.1016\/j.ymthe.2017.03.008_bib110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1073\/pnas.88.3.723","article-title":"Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse","volume":"88","author":"Connell","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib111","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng0393-208","article-title":"A null mutation in the human peripherin\/RDS gene in a family with autosomal dominant retinitis punctata albescens","volume":"3","author":"Kajiwara","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib112","first-page":"3154","article-title":"RDS gene mutations causing retinitis pigmentosa or macular degeneration lead to the same abnormality in photoreceptor function","volume":"35","author":"Kemp","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archopht.1996.01100130068011","article-title":"Autosomal dominant cone-rod dystrophy associated with mutations in codon 244 (Asn244His) and codon 184 (Tyr184Ser) of the peripherin\/RDS gene","volume":"114","author":"Nakazawa","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2017.03.008_bib114","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng0693-130","article-title":"Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa","volume":"4","author":"McLaughlin","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib115","first-page":"S919","article-title":"Retinopathy in mice transgenic for a mutant human TIMP3 gene that causes Sorsby Fundus Dystrophy","volume":"40","author":"Gupta","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib116","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1294-352","article-title":"Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby\u2019s fundus dystrophy","volume":"8","author":"Weber","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib117","first-page":"509","article-title":"Rom1 converts Y141C-Prph2-associated pattern dystrophy to retinitis pigmentosa","volume":"26","author":"Conley","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib118","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.8202715","article-title":"Digenic retinitis pigmentosa due to mutations at the unlinked peripherin\/RDS and ROM1 loci","volume":"264","author":"Kajiwara","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.03.008_bib119","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/hmg\/ddn327","article-title":"New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene","volume":"18","author":"Sakamoto","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1295-468","article-title":"Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase","volume":"11","author":"Huang","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib121","first-page":"2978","article-title":"Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness)","volume":"40","author":"Chen","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2017.03.008_bib122","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ng0795-360","article-title":"A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese","volume":"10","author":"Fuchs","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib123","first-page":"1238","article-title":"A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy","volume":"56","author":"Lamminen","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/470","article-title":"Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice","volume":"19","author":"Liu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/374060a0","article-title":"Defective myosin VIIA gene responsible for Usher syndrome type 1B","volume":"374","author":"Weil","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.03.008_bib126","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/hmg\/11.9.993","article-title":"Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration","volume":"11","author":"Zhang","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib127","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0596-35","article-title":"A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)","volume":"13","author":"Meindl","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib128","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1073\/pnas.95.3.1271","article-title":"A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype","volume":"95","author":"Semple-Rowland","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng1296-461","article-title":"Retinal-specific guanylate cyclase gene mutations in Leber\u2019s congenital amaurosis","volume":"14","author":"Perrault","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib130","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/hmg\/5.9.1339","article-title":"A family with Stickler syndrome type 2 has a mutation in the COL11A1\u00a0gene resulting in the substitution of glycine 97 by valine in alpha 1\u00a0(XI) collagen","volume":"5","author":"Richards","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2017.03.008_bib132","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/mgme.1999.2828","article-title":"A murine model for juvenile NCL: gene targeting of mouse Cln3","volume":"66","author":"Greene","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.03.008_bib133","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.03.008_bib134","doi-asserted-by":"crossref","first-page":"13870","DOI":"10.1073\/pnas.93.24.13870","article-title":"The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney","volume":"93","author":"Favor","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.03.008_bib135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng1386","article-title":"Identification and characterization of rod-derived cone viability factor","volume":"36","author":"L\u00e9veillard","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2017.03.008_bib136","doi-asserted-by":"crossref","first-page":"e0157411","DOI":"10.1371\/journal.pone.0157411","article-title":"Erythropoietin slows photoreceptor cell death in a mouse model of autosomal dominant retinitis pigmentosa","volume":"11","author":"Rex","year":"2016","journal-title":"PLoS One"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:54:27Z","timestamp":1657673667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":136,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1525001617301065"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.008","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}